ANDA 78105, held by Chartwell Molecular. Albuterol Sulfate.
As of Nov 16, 2026, ANDA 78105 (Albuterol Sulfate), held by Chartwell Molecular, was first approved by FDA on Dec 27, 2006, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 27, 2006 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Albuterol SulfateEQ 2MG BASE/5ML ยท syrup;oral | Albuterol Sulfate | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters